前列康片联合盐酸坦洛新缓释片治疗慢性前列腺炎的疗效分析  

Clinical Observation of Tamsulosin Hydrochloride Sustained Release Tablets Combined with Qianliekang Tablets in Treatment of Chronic Prostatitis

作　　者：郑涛 Zheng Tao(Department of Urology,Xiegang Hospital of Dongguan,Dongguan 523590,China)

机构地区：[1]东莞市谢岗镇人民医院泌尿外科,广东东莞523590

出　　处：《哈尔滨医药》2018年第1期17-19,共3页Harbin Medical Journal

摘　　要：目的探讨盐酸坦洛新缓释片联合前列康片治疗慢性前列腺炎的临床疗效。方法按标准选取2015年6月至2016年12月于我院治疗的慢性前列腺炎患者114例,按照随机法分为对照组和试验组。对照组在常规对症治疗基础上口服前列康片;试验组在对照组的基础上加服盐酸坦洛新缓释片,治疗6周后比较两组患者的治疗效果。结果试验组总有效率为87.72%,对照组总有效率为70.18%,两组差异有统计学意义(P<0.05)。治疗后,两组患者疼痛评分、排尿评分、生活质量评分以及总分均优于治疗前,且试验组治疗后评分明显低于对照组治疗后,差异均有统计学意义(P<0.05)。在前列腺液的白细胞计数和p H值方面,试验组治疗后效果优于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率均为3.5%,差异无统计学意义(P>0.05)。结论对于慢性前列腺炎的治疗,前列康片联合盐酸坦洛新缓释片治疗具有显著临床疗效,且安全性好,值得推广应用。Objective To investigate the clinical efficacy of tamsulosin hydrochloride sustained-release tablets combined with Qianlie Kang Tablet in treatment of chronic prostatitis.Methods According to the standard,114cases of chronic prostatitis treated in our hospital from June2015to December2016were randomly divided into the control group and the experimental group.The control group was treated with conventional symptomatic treatment,and oral QianLieKang tablets treatment;experimental group plus tamsulosin hydrochloride sustained release tablets hydrochloride treatment on the basis of the control group,the treatment effects were compared between the two groups of patients in the two groups after6weeks of treatment.Results The total effective rate of the experimental group was87.72%,and the total effective rate of the control group was70.18%.The difference between the two groups was statistically significant(P约0.05).After treatment,two groups of patients with pain score,urination score,life quality score and total score were better than before treatment,the difference was statistically significant(P约0.05),while the experimental group after treatment was significantly lower than the control group,the difference was statistically significant(P约0.05).In the white blood cell count and pH value of prostate fluid,the effect of the experimental group was better than that of the control group,the difference was statistically significant(P约0.05).The incidence of adverse reactions in the two groups was3.5%,and there was no significant difference(P跃0.05).Conclusion Tamsulosin hydrochloride sustained-release tablets combined with QianLieKang tablets has better clinical efficacy in the treatment of chronic prostatitis,and good safety,it is worthy of popularization and application.

关 键 词：前列康片 盐酸坦洛新缓释片 慢性前列腺炎 

分 类 号：R697.3[医药卫生—泌尿科学]